A federal appeals court has unanimously rejected an attempt by a group of Republican states to intervene in a lawsuit seeking fewer restrictions for the abortion pill mifepristone.
Mifepristone is subject to certain safety restrictions imposed by the FDA under a Risk Evaluation and Mitigation Strategy, or REMS. Regulators loosened…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
